1.23
price down icon8.55%   -0.115
after-market After Hours: 1.20 -0.03 -2.44%
loading

Pepgen Inc Stock (PEPG) Latest News

pulisher
Feb 06, 2025

Taking on analysts’ expectations and winning: PepGen Inc (PEPG) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

PEPG’s 2023 Market Dance: Down -64.64% – Time to Invest? - The InvestChronicle

Feb 06, 2025
pulisher
Feb 06, 2025

why PepGen Inc [PEPG] is a Good Choice for Investors After New Price Target of $12.80 - The DBT News

Feb 06, 2025
pulisher
Feb 05, 2025

FY2029 Earnings Estimate for PepGen Issued By HC Wainwright - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - PR Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

Market Update: PepGen Inc (PEPG) Sees Negative Movement, Closing at 1.25 - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

HC Wainwright Cuts PepGen (NASDAQ:PEPG) Price Target to $16.00 - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

What is HC Wainwright’s Estimate for PepGen FY2025 Earnings? - Defense World

Feb 03, 2025
pulisher
Feb 01, 2025

H.C. Wainwright cuts PepGen stock target to $16, maintains Buy rating - Investing.com India

Feb 01, 2025
pulisher
Feb 01, 2025

JPMorgan Chase & Co. Increases Holdings in PepGen Inc. (NASDAQ:PEPG) - Defense World

Feb 01, 2025
pulisher
Feb 01, 2025

HC Wainwright Lowers PepGen (NASDAQ:PEPG) Price Target to $16.00 - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

PepGen price target lowered to $16 from $26 at H.C. Wainwright - Yahoo Finance

Jan 31, 2025
pulisher
Jan 31, 2025

PepGen stock plunges to 52-week low of $1.76 amid market challenges - Investing.com Australia

Jan 31, 2025
pulisher
Jan 29, 2025

PepGen continues trials for DMD treatment, addresses safety concerns By Investing.com - Investing.com South Africa

Jan 29, 2025
pulisher
Jan 29, 2025

PepGen continues trials for DMD treatment, addresses safety concerns - Investing.com India

Jan 29, 2025
pulisher
Jan 29, 2025

PepGen Announces CONNECT Program Updates - Business Wire

Jan 29, 2025
pulisher
Jan 28, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - PR Newswire

Jan 28, 2025
pulisher
Jan 28, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 22, 2025

PepGen stock hits 52-week low at $2.21 amid market challenges - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Barclays PLC Has $189,000 Stake in PepGen Inc. (NASDAQ:PEPG) - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

PepGen stock hits 52-week low at $2.21 amid market challenges By Investing.com - Investing.com South Africa

Jan 21, 2025
pulisher
Jan 17, 2025

PepGen Inc. (NASDAQ:PEPG) Short Interest Down 14.1% in December - MarketBeat

Jan 17, 2025
pulisher
Jan 14, 2025

PepGen stock hits 52-week low at $2.88 amid market challenges - Investing.com Australia

Jan 14, 2025
pulisher
Jan 13, 2025

PepGen stock hits 52-week low at $2.88 amid market challenges By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 12, 2025

Jane Street Group LLC Purchases 6,254 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World

Jan 12, 2025
pulisher
Jan 08, 2025

All You Need to Know About PepGen (PEPG) Rating Upgrade to Buy - Yahoo Finance

Jan 08, 2025
pulisher
Jan 07, 2025

Barclays PLC Has $189,000 Stock Position in PepGen Inc. (NASDAQ:PEPG) - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Geode Capital Management LLC Has $3.21 Million Stock Holdings in PepGen Inc. (NASDAQ:PEPG) - Defense World

Jan 07, 2025
pulisher
Dec 20, 2024

Wedbush Comments on PepGen’s FY2028 Earnings (NASDAQ:PEPG) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Fmr LLC Sells 327,160 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Wedbush Has Bullish Forecast for PepGen FY2028 Earnings - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

FDA Pauses PepGen’s DMD Drug Trial in the US - AJMC.com Managed Markets Network

Dec 19, 2024
pulisher
Dec 17, 2024

PepGen stock craters 35% on FDA clinical hold - MSN

Dec 17, 2024
pulisher
Dec 17, 2024

FDA halts PepGen's DMD trial; ongoing study continues By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 17, 2024

PepGen (NASDAQ:PEPG) Downgraded by Bank of America to Underperform - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

PepGen stock touches 52-week low at $2.9 amid market challenges - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

FDA halts PepGen's DMD trial; ongoing study continues - Investing.com India

Dec 16, 2024
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):